Published in Tissue Eng Part A on August 19, 2014
High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol (1969) 20.26
Preparation of isolated rat liver cells. Methods Cell Biol (1976) 17.96
Vascularization in tissue engineering. Trends Biotechnol (2008) 2.93
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
Designing cell-compatible hydrogels for biomedical applications. Science (2012) 2.47
Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol (1975) 2.42
Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater (2006) 1.59
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials (2005) 1.33
Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology (2002) 1.33
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer (2008) 1.31
VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res (2007) 1.24
Heparanase involvement in physiology and disease. Cell Mol Life Sci (2008) 1.19
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology (1996) 1.15
Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans. PLoS One (2008) 1.14
Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J Clin Invest (2003) 1.09
Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. Tissue Eng (2006) 1.07
Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology (2005) 1.07
Protein-polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering. Biomaterials (2007) 1.06
Expression of stem cell factor and its receptor c-Kit during the development of intrahepatic cholangiocarcinoma. Lab Invest (2009) 1.01
Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater (2005) 1.01
Hepatocyte transplantation in animal models. Liver Transpl (2009) 0.97
Recent advances in liver transplantation. Mayo Clin Proc (2003) 0.94
Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. J Hepatol (2005) 0.94
Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant (2010) 0.92
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver. Hepatology (2013) 0.90
111Indium labeling of hepatocytes for analysis of short-term biodistribution of transplanted cells. Hepatology (1994) 0.89
Stem cell factor and its receptor, c-kit, are important for hepatocyte proliferation in wild-type and tumor necrosis factor receptor-1 knockout mice after 70% hepatectomy. Surgery (2008) 0.88
Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther (2003) 0.87
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans (2006) 0.87
In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng Part C Methods (2010) 0.84
In vitro assays for induction of drug metabolism. Methods Mol Biol (2009) 0.83
Structural investigation of PEG-fibrinogen conjugates. J Mater Sci Mater Med (2009) 0.80
HVEGF165 increases survival of transplanted hepatocytes within portal radicles: suggested mechanism for early cell engraftment. Cell Transplant (2005) 0.79
Heparanase enhances early hepatocyte inclusion in the recipient liver after transplantation in partially hepatectomized rats. Tissue Eng Part A (2008) 0.77
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med (2014) 4.90
Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study. Eur J Gastroenterol Hepatol (2011) 2.13
Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials (2005) 1.82
Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater (2006) 1.59
The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials (2008) 1.51
Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr (2013) 1.47
Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels. Stem Cells (2007) 1.42
Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. J Hepatol (2005) 1.41
Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A (2003) 1.41
The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials (2005) 1.33
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience. HPB (Oxford) (2013) 1.27
Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J (2008) 1.25
Laser photoablation of guidance microchannels into hydrogels directs cell growth in three dimensions. Biophys J (2009) 1.08
Protein-polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering. Biomaterials (2007) 1.06
A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials (2011) 1.03
Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. Ultrasound Med Biol (2004) 1.03
Ultrasound-induced angiogenic response in endothelial cells. Ultrasound Med Biol (2007) 1.02
Immobilized fibrinogen in PEG hydrogels does not improve chondrocyte-mediated matrix deposition in response to mechanical stimulation. Biotechnol Bioeng (2006) 0.97
Esophageal varices: evaluation with esophagography with barium versus endoscopic gastroduodenoscopy in patients with compensated cirrhosis--blinded prospective study. Radiology (2005) 0.96
Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. Biomaterials (2013) 0.96
A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol (2008) 0.96
Microscale control of stiffness in a cell-adhesive substrate using microfluidics-based lithography. Angew Chem Int Ed Engl (2009) 0.96
Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction. J Hepatol (2008) 0.95
Biomimetics of the Extracellular Matrix: An Integrated Three-Dimensional Fiber-Hydrogel Composite for Cartilage Tissue Engineering. Smart Struct Syst (2011) 0.95
pH-stimulated DNA hydrogels exhibiting shape-memory properties. Adv Mater (2014) 0.94
Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity. Acta Biomater (2012) 0.94
A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J Biomed Mater Res A (2007) 0.93
Stress among the family caregivers of liver transplant recipients. Prog Transplant (2007) 0.92
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Mid-term results of stapled hemorrhoidopexy for third- and fourth-degree hemorrhoids--correlation with the histological features of the resected tissue. World J Surg (2007) 0.90
Controlling the cellular organization of tissue-engineered cardiac constructs. Ann N Y Acad Sci (2004) 0.89
The influence of biological motifs and dynamic mechanical stimulation in hydrogel scaffold systems on the phenotype of chondrocytes. Biomaterials (2010) 0.88
The differential effect of scaffold composition and architecture on chondrocyte response to mechanical stimulation. Biomaterials (2008) 0.87
Capillary morphogenesis in PEG-collagen hydrogels. Biomaterials (2013) 0.87
Polymer-conjugated albumin and fibrinogen composite hydrogels as cell scaffolds designed for affinity-based drug delivery. Acta Biomater (2010) 0.86
Self-assembled Fmoc-peptides as a platform for the formation of nanostructures and hydrogels. Biomacromolecules (2009) 0.86
Recurrent small intestinal ileus secondary to valsartan treatment. J Clin Gastroenterol (2014) 0.86
The biocompatibility of PluronicF127 fibrinogen-based hydrogels. Biomaterials (2010) 0.85
Compositional alterations of fibrin-based materials for regulating in vitro neural outgrowth. Tissue Eng Part A (2008) 0.84
Switchable catalytic acrylamide hydrogels cross-linked by hemin/G-quadruplexes. Nano Lett (2013) 0.84
Biological and mechanical implications of PEGylating proteins into hydrogel biomaterials. Biomaterials (2011) 0.83
Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. Int J Gen Med (2013) 0.83
Real-time monitoring of force response measured in mechanically stimulated tissue-engineered cartilage. Artif Organs (2009) 0.83
Endoluminal hydrogel films made of alginate and polyethylene glycol: physical characteristics and drug-eluting properties. J Biomed Mater Res A (2005) 0.82
A finite element model of cell-matrix interactions to study the differential effect of scaffold composition on chondrogenic response to mechanical stimulation. J Biomech Eng (2011) 0.82
The role of matrix metalloproteinases in regulating neuronal and nonneuronal cell invasion into PEGylated fibrinogen hydrogels. Biomaterials (2010) 0.81
Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford) (2011) 0.81
Structural investigation of PEG-fibrinogen conjugates. J Mater Sci Mater Med (2009) 0.80
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease. J Crohns Colitis (2015) 0.80
Two successful pregnancies in a patient with advanced liver cirrhosis and hepatopulmonary syndrome. Gastroenterol Hepatol (N Y) (2007) 0.80
Seamless metallic coating and surface adhesion of self-assembled bioinspired nanostructures based on di-(3,4-dihydroxy-L-phenylalanine) peptide motif. ACS Nano (2014) 0.79
HVEGF165 increases survival of transplanted hepatocytes within portal radicles: suggested mechanism for early cell engraftment. Cell Transplant (2005) 0.79
Heparanase accelerates the proliferation of both hepatocytes and endothelial cells early after partial hepatectomy. Exp Mol Pathol (2012) 0.79
Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol (2004) 0.79
Attempted application of bioengineered/biosynthetic supporting matrices with phosphatidylinositol-trisphosphate-enhancing substances to organ culture of human primordial follicles. J Assist Reprod Genet (2013) 0.79
Reversible Ag(+)-crosslinked DNA hydrogels. Chem Commun (Camb) (2014) 0.79
Hydrogels for cardiac tissue regeneration. Biomed Mater Eng (2008) 0.78
Nanostructuring PEG-fibrinogen hydrogels to control cellular morphogenesis. Biomaterials (2011) 0.78
Acute hepatitis C in Israel: a predominantly iatrogenic disease? J Gastroenterol Hepatol (2007) 0.78
Influence of soluble PEG-OH incorporation in a 3D cell-laden PEG-fibrinogen (PF) hydrogel on smooth muscle cell morphology and growth. J Biomater Sci Polym Ed (2013) 0.77
Heparanase enhances early hepatocyte inclusion in the recipient liver after transplantation in partially hepatectomized rats. Tissue Eng Part A (2008) 0.77
Periodontal changes in liver cirrhosis and post-transplantation patients. II: radiographic findings:. J Periodontol (2002) 0.77
Alveolar bone loss in liver transplantation patients: relationship with prolonged steroid treatment and parathyroid hormone levels. J Clin Periodontol (2007) 0.77
The rheological and structural properties of Fmoc-peptide-based hydrogels: the effect of aromatic molecular architecture on self-assembly and physical characteristics. Langmuir (2012) 0.77
Gaucher's disease type I: a disease masked by the presence of abnormal laboratory tests common to primary liver disease. Eur J Gastroenterol Hepatol (2010) 0.77
Periodontal status in post-liver transplantation patients: 10 years of follow-up. Quintessence Int (2012) 0.76
Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model. Biomaterials (2013) 0.76
Stimulus-responsive hydrogels made from biosynthetic fibrinogen conjugates for tissue engineering: structural characterization. Langmuir (2011) 0.76
Fluorescent DNA hydrogels composed of nucleic acid-stabilized silver nanoclusters. Small (2013) 0.76
In-situ architectures designed in 3D cell-laden hydrogels using microscopic laser photolithography. Adv Mater (2015) 0.76
Time-dependent cellular morphogenesis and matrix stiffening in proteolytically responsive hydrogels. Acta Biomater (2013) 0.76
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer. Chemotherapy (2008) 0.76
Fabrication of PEGylated fibrinogen: a versatile injectable hydrogel biomaterial. Methods Mol Biol (2014) 0.76
Nanostructuring biosynthetic hydrogels for tissue engineering: a cellular and structural analysis. Acta Biomater (2011) 0.76
Nanostructuring of PEG-fibrinogen polymeric scaffolds. Acta Biomater (2009) 0.75
The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model. J Tissue Eng Regen Med (2010) 0.75
Spontaneous bacterial peritonitis with a very high leukocyte count in ascitic fluid caused by Haemophilus influenzae. Int J Gen Med (2013) 0.75
Cell morphology in injectable nanostructured biosynthetic hydrogels. J Biomed Mater Res A (2014) 0.75
Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2. J Clin Gastroenterol (2008) 0.75
Phloroglucinol-based biomimetic adhesives for medical applications. Acta Biomater (2008) 0.75
Exposure during pancreatic surgery. Do we have to examine the falciform and round ligaments for pancreatic cancer metastasis? JOP (2011) 0.75
[Outcome of treatment with peg-interferon and ribavirin in HIV-HCV co-infected patients: "real life" single center experience]. Harefuah (2012) 0.75